CFC-based inhalers on way out
Beximco Pharma formally shuts down its CFC-based aerosol inhaler plant in Bangladesh
bdnews24.com News Service
bdnews24.com
Published :
15 Mar 2012, 03:42 PM
Updated :
09 Aug 2022, 03:33 PM
Dhaka, Mar 15 (bdnews24.com) – A leading drug-maker has formally shut down its CFC-based aerosol inhaler plant in Bangladesh complying with the Montreal Protocol that controls use of ozone layer-depleting gas.
Beximco Pharmaceuticals Ltd's transitions from CFC-propelled inhalers to HFA-based ones marked the 25th anniversary of the 1987 Protocol that has been signed by 189 countries.
Marking the transition, health minister AFM Ruhal Haque on Thursday unveiled a commemorative plaque and inaugurated a new plant of HFA ((hydrofluoroalkane) aerosol inhaler at the Beximco Pharma's factory premises at Tongi.
"It also marks a significant milestone in cooperation between government and pharmaceutical industry in their joint efforts with the international community to protect the environment," Rabbur Reza, chief operating officer of Beximco Pharma, said.
Researchers took more than 20 years to develop HFA-propelled inhalers as CFCs (chlorofluorocarbon) are harmful to the environment because they decrease the protective ozone layer above the earth.
Although developed world has phased out the medical use of CFCs before 2010, Bangladesh as a least developed country got extra two years to stop producing CFC-inhalers.
"We are proud to be among the first few companies in the world to have made such a transition from using CFC gases in medical inhalers," Reza, also a member of Montreal Protocol Medical Technical Options Committee (MTOC), said.
He also praised the physicians for helping the switch.
Physicians' body, Bangladesh Association of Lung Foundation, is working closely with the industries to phase out CFCs.
Kristine Whorlow, a member of the Montreal Protocol MTOC who observes Bangladesh's progress in phasing out CFCs from medical use, told bdnews24.com the country had made 'quick' progress.
"You have to convince people who use inhalers," she said while attending the ceremony at Tongi.
"The HFA-propelled inhalers may taste different. Patients may feel less force, may feel less cold. So they need to be reassured that the change is very good for the environment reason."
Prof Rashidul Hassan, president of Bangladesh Association of Lung Foundation, told bdnews24.com they had trained general practitioners to support patients in using HFA-propelled inhalers.
According to industry sources, Bangladesh exports inhalers after meeting annual domestic demand of 6-7 million canisters.
Lung experts say the number of asthma patients who need inhalers is increasing by the day due to poor air quality and other environmental factors.
bdnews24.com/nih/bd/2054h